Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing
Document ID: FDA-2010-N-0477-0001
Comments
Total: 70
-
Wockhardt Limited (Wockhardt USA LLC) - Comment
Posted : 01/05/2011 ID :FDA-2010-N-0477-0069 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
PAREXEL International - Comment
Posted : 01/05/2011 ID :FDA-2010-N-0477-0070 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Generic Pharmaceutical Association - Comment
Posted : 01/05/2011 ID :FDA-2010-N-0477-0071 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Russ Lehrman - Testimony
Posted : 01/05/2011 ID :FDA-2010-N-0477-0072 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Universities Allied for Essential Medicines - Comment
Posted : 01/05/2011 ID :FDA-2010-N-0477-0073 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Express Scripts - Comment
Posted : 01/05/2011 ID :FDA-2010-N-0477-0074 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Consumers Union - Comment
Posted : 01/31/2011 ID :FDA-2010-N-0477-0075 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Jonathan Rudolph Kominek Stroud - Comment
Posted : 10/21/2011 ID :FDA-2010-N-0477-0076 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Bristol-Myers Squibb Company - Comment
Posted : 02/03/2012 ID :FDA-2010-N-0477-0077 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
U.S. Pharmacopeia (USP) - Comment
Posted : 02/07/2012 ID :FDA-2010-N-0477-0078 Agency : FDA -
Dec 31,2010 11:59 PM ET